Skip to content
The National Council logo

Archive: Drug Pricing

Capitol Connector
Your source for the latest updates from Capitol Hill. We translate policy into practice so you can learn how policy trends will affect your work and how best to prepare.

Health Groups Convene Briefing on Medicare Out-of-Pocket Caps

June 27, 2019 | Drug Pricing | Medicare | Comments
Image related to this article

Wendolyn Ebbert

Intern, Policy & Practice Improvement

On Tuesday, the MAPRx Coalition, which includes the National Council, hosted a Congressional staff briefing featuring a panel of advocates representing the AIDS Institute, the American Cancer Society, the National Council on Aging and Avalere Health. Speakers provided an overview of how Medicare Part D offers access to prescription drugs and the need for legislation that would place a cap on out-of-pocket costs for these medications. Currently, costs for medications that treat life-threatening illnesses such as cancer, HIV/AIDS, autoimmune diseases, which often co-occur with mental illness and substance use disorder, amount to tens of thousands of dollars per year per person. If Congress does not act, these expenses are set to increase in 2020, having a devastating impact for over 1 million Medicare enrollees.

Read More |  View Comments

Share on LinkedIn

Congress Seeks to Address Rising Health Care Costs

May 30, 2019 | Drug Pricing | Medicare | Comments
Image related to this article

Shelley Starkey

Both the House and Senate have released bipartisan proposals in the last week to lower out-of-pocket health care costs across the country. The Senate Health, Education, Labor, and Pensions (HELP) Committee has released a sweeping proposal to address surprise medical billing, increase transparency within the health care industry, and bring down drug costs. Meanwhile, leaders of the House Ways and Means and Energy and Commerce Committees are seeking input on draft legislation to cap out-of-pocket costs under Medicare Part D, the program’s prescription drug benefit.

Read More |  View Comments

Share on LinkedIn

Finalized Rule from CMS Preserves Medicare’s Six Protected Classes

Image related to this article

Shelley Starkey

The Centers for Medicare and Medicaid Services (CMS) released a final rule on Thursday aimed at addressing rising drug prices and out-of-pocket expenses under Medicare Part D and Medicare Advantage. Notably, the final rule did not include previously-proposed measures that would have provided exceptions to Medicare’s “six protected classes,” a policy that ensures beneficiaries with complex health conditions, including mental illness, have access to a full range of medication treatment options. The announcement comes after six months of opposition to the proposals from Members of Congress and patient and provider advocates, including the National Council for Behavioral Health.

Read More |  View Comments

Share on LinkedIn

Trump Announces Blueprint to Lower Drug Prices

Image related to this article

Stephanie Pellitt

, National Council for Behavioral Health

Last Friday, President Trump announced the Administration’s plan to lower drug prices in a speech entitled ‘American Patients First,’ which highlights steps the Administration has taken, outlines future actions, and requests public comment on “even bolder actions” to bring down drug prices. The wide-ranging proposals include reforms to Medicare Part D and Part B, Medicaid, the Food and Drug Administration (FDA), the 340B Drug Discount program, and more.

Read More |  View Comments

Share on LinkedIn
©2019 National Council for Behavioral Health. All Rights Reserved.
The National Council for Behavioral Health is a 501(c)(3) nonprofit association (EIN 23-7092671).